Arnold M. Baskies - 05 Jan 2026 Form 4 Insider Report for Anixa Biosciences Inc (ANIX)

Role: Director
Signature: /s/ Arnold M. Baskies
Issuer symbol: ANIX
Transactions as of: 05 Jan 2026
Net transactions value: $0
Form type: 4
Filing time: 06 Jan 2026, 19:40:10 UTC
Previous filing: 21 Jul 2025
Next filing: 29 Jan 2026
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Baskies Arnold M	Director	C/O ANIXA BIOSCIENCES, INC., 3150 ALMADEN EXPRESSWAY, SUITE 250, SAN JOSE,	/s/ Arnold M. Baskies	06 Jan 2026	0001683567

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ANIX	Employee Stock Option	Award	$0	+25,000		$0.000000	25,000	05 Jan 2026	Common Stock	25,000	$3.18	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Right-To-Buy, granted under the Anixa Biosciences, Inc. 2018 Share Incentive Plan.
F2	The options vest and become exercisable in twelve (12) equal monthly installments beginning January 31, 2026.